Simponi ARIA IV Infusion Therapy

What is Simponi ARIA?

Simponi ARIA (golimumab) is a biologic drug used to treat adults with moderate to severe ​rheumatoid arthritis (RA) (in combination with methotrexate), ​active psoriatic arthritis (PsA), and ​active ankylosing spondylitis (AS). 

How does Simponi ARIA work?

Tumor necrosis factor (TNF)-alpha is a protein in the immune system that helps regulate immune cells and inflammation in the body. Patients with RA, PsA, or AS have bodies that produce too much TNF-alpha, which can cause the immune system to mistakenly attack cells in the joints, spine, and skin. Remicade reduces inflammation and symptoms of these conditions by blocking TNF-alpha in the body. 

How is Simponi ARIA administered?

Simponi ARIA is administered intravenously. The first two infusions are given during Week 0 and Week 4, then once every 8 weeks thereafter. Each infusion takes about 30 minutes. Doses are based on body weight. 

Click here to view the pharmaceutical website for Simponi ARIA.

Simponi ARIA patient Assistance program

• Janssen CarePath - SIMPONI ARIA Cost Support

This product may be used to treat other conditions not listed. If you are currently using or have a physician’s order to begin using this product for an unlisted condition and you have questions about whether or not we can offer you infusion services, please call our office or fill out a form and a member of our team will reach out to you as soon as possible.

If you’d like more information about the other treatment options we offer, please visit the IVIg infusions or biologic injections pages to learn more.